MEPPSTM performs advanced metabolomics analysis using chemoselective probes.
Application of this method enhances the mass spectrometric sensitivity by a factor of up to six orders-of-magnitude (1 million) that will lead to the discovery of unidentified metabolites. This method advances the scope of metabolomics-driven biomarker discovery projects and can lead to the development of new therapeutics and diagnostics. Applicable for any biological sample including human and microbiota samples, which is a rapidly emerging field. The method has a diverse research field application including Metabolomics, Microbiome, Medical Sciences, Biomarker Discovery, Diagnostics, Toxicology.
Contact: Daniel Globisch / Daniel.globisch[at]mepps-bioscience.com
For more information visit: https://www.kemi.uu.se/bmc/research/analytical-chemistry/research-groups/globisch-group